![](/img/cover-not-exists.png)
Establishing the Cost-Effectiveness of New Pharmaceuticals under Conditions of Uncertainty—When Is There Sufficient Evidence?
Mark Sculpher, Karl ClaxtonVolume:
8
Year:
2005
Language:
english
Pages:
14
DOI:
10.1111/j.1524-4733.2005.00033.x
File:
PDF, 120 KB
english, 2005